- Home
- ACEL vs ABSI Comparison
ACEL vs ABSI Comparison
Compare ACEL & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACEL | ABSI |
|---|---|---|
| Founded | 2009 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 997.8M |
| IPO Year | 2017 | 2021 |
Fundamental Metrics
Financial Performance| Metric | ACEL | ABSI |
|---|---|---|
| Price | $12.00 | $9.54 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 4 |
| Target Price | ★ $14.67 | $6.96 |
| AVG Volume (30 Days) | 258.6K | ★ 2.6M |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 46.34 | 10.64 |
| EPS | ★ 0.32 | N/A |
| Revenue | N/A | ★ $4,534,000.00 |
| Revenue This Year | $7.07 | $215.96 |
| Revenue Next Year | $2.81 | $319.10 |
| P/E Ratio | $37.81 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.55 | $2.24 |
| 52 Week High | $14.00 | $12.06 |
Technical Indicators
Market Signals| Indicator | ACEL | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 43.93 | 56.94 |
| Support Level | $11.74 | $2.56 |
| Resistance Level | $12.65 | $12.06 |
| Average True Range (ATR) | 0.35 | 0.56 |
| MACD | -0.01 | 0.11 |
| Stochastic Oscillator | 31.30 | 77.11 |
Price Performance
Historical ComparisonAbout ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.